BTD and diabetes mellitus: Future studies aiming at confirming this hypothesis should involve a higher number of samples and could eventually expand the spectrum of BTD enzyme activity as a biomarker beyond GSDs to detect perturbed gluconeogenesis and lipogenesis, such as in diabetes mellitus.